Joseph A C Delaney1,2, Nels C Olson3, Colleen M Sitlani4, Alison E Fohner5, Sally A Huber3, Alan L Landay6, Susan R Heckbert5, Russell P Tracy3,7, Bruce M Psaty8,9, Matt Feinstein10, Margaret F Doyle3. 1. College of Pharmacy, University of Manitoba, Winnipeg, MB, Canada. Joseph.delaney@umanitoba.ca. 2. Department of Epidemiology, University of Washington, Seattle, WA, USA. Joseph.delaney@umanitoba.ca. 3. Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA. 4. Department of Medicine, University of Washington, Seattle, WA, USA. 5. Department of Epidemiology, University of Washington, Seattle, WA, USA. 6. Division of Geriatrics, Gerontology and Palliative Medicine, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. 7. Department of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT, USA. 8. Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, WA, USA. 9. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. 10. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
BACKGROUND: Hypertension is a major source of cardiovascular morbidity and mortality. Recent evidence from mouse models, genetic, and cross-sectional human studies suggest increased proportions of selected immune cell subsets may be associated with levels of systolic blood pressure (SBP). METHODS: We assayed immune cells from cryopreserved samples collected at the baseline examination (2000-2002) from 1195 participants from the multi-ethnic study of atherosclerosis (MESA). We used linear mixed models, with adjustment for age, sex, race/ethnicity, smoking, exercise, body mass index, education, diabetes, and cytomegalovirus titers, to estimate the associations between 30 immune cell subsets (4 of which were a priori hypotheses) and repeated measures of SBP (baseline and up to four follow-up measures) over 10 years. The analysis provides estimates of the association with blood pressure level. RESULTS: The mean age of the MESA participants at baseline was 64 ± 10 years and 53% were male. A one standard deviation (1-SD) increment in the proportion of γδ T cells was associated with 2.40 mmHg [95% confidence interval (CI) 1.34-3.42] higher average systolic blood pressure; and for natural killer cells, a 1-SD increment was associated with 1.88 mmHg (95% CI 0.82-2.94) higher average level of systolic blood pressure. A 1-SD increment in classical monocytes (CD14++CD16-) was associated with 2.01 mmHG (95% CI 0.79-3.24) lower average systolic blood pressure. There were no associations of CD4+ T helper cell subsets with average systolic blood pressure. CONCLUSION: These findings suggest that the innate immune system plays a role in levels of SBP whereas there were no associations with adaptive immune cells.
BACKGROUND:Hypertension is a major source of cardiovascular morbidity and mortality. Recent evidence from mouse models, genetic, and cross-sectional human studies suggest increased proportions of selected immune cell subsets may be associated with levels of systolic blood pressure (SBP). METHODS: We assayed immune cells from cryopreserved samples collected at the baseline examination (2000-2002) from 1195 participants from the multi-ethnic study of atherosclerosis (MESA). We used linear mixed models, with adjustment for age, sex, race/ethnicity, smoking, exercise, body mass index, education, diabetes, and cytomegalovirus titers, to estimate the associations between 30 immune cell subsets (4 of which were a priori hypotheses) and repeated measures of SBP (baseline and up to four follow-up measures) over 10 years. The analysis provides estimates of the association with blood pressure level. RESULTS: The mean age of the MESAparticipants at baseline was 64 ± 10 years and 53% were male. A one standard deviation (1-SD) increment in the proportion of γδ T cells was associated with 2.40 mmHg [95% confidence interval (CI) 1.34-3.42] higher average systolic blood pressure; and for natural killer cells, a 1-SD increment was associated with 1.88 mmHg (95% CI 0.82-2.94) higher average level of systolic blood pressure. A 1-SD increment in classical monocytes (CD14++CD16-) was associated with 2.01 mmHG (95% CI 0.79-3.24) lower average systolic blood pressure. There were no associations of CD4+ T helper cell subsets with average systolic blood pressure. CONCLUSION: These findings suggest that the innate immune system plays a role in levels of SBP whereas there were no associations with adaptive immune cells.
Authors: D C Rao; Yun J Sung; Thomas W Winkler; Karen Schwander; Ingrid Borecki; L Adrienne Cupples; W James Gauderman; Kenneth Rice; Patricia B Munroe; Bruce M Psaty Journal: Circ Cardiovasc Genet Date: 2017-06
Authors: Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He Journal: JAMA Cardiol Date: 2017-07-01 Impact factor: 14.676
Authors: Nels C Olson; Reem Sallam; Margaret F Doyle; Russell P Tracy; Sally A Huber Journal: J Cardiovasc Transl Res Date: 2013-08-07 Impact factor: 4.132
Authors: Howard D Sesso; Monik C Jiménez; Lu Wang; Paul M Ridker; Julie E Buring; J Michael Gaziano Journal: J Am Heart Assoc Date: 2015-09-21 Impact factor: 5.501
Authors: Yingxi Chen; Neal D Freedman; Paul S Albert; Rachel R Huxley; Meredith S Shiels; Diana R Withrow; Susan Spillane; Tiffany M Powell-Wiley; Amy Berrington de González Journal: JAMA Cardiol Date: 2019-12-01 Impact factor: 14.676
Authors: Rinaldo Rodrigues Dos Passos Junior; Gisele Facholi Bomfim; Fernanda R Giachini; Rita C Tostes; Victor Vitorino Lima Journal: Front Immunol Date: 2022-03-17 Impact factor: 7.561
Authors: Arjun Sinha; Adovich S Rivera; Margaret F Doyle; Colleen Sitlani; Alison Fohner; Sally A Huber; Nels C Olson; Joao Ac Lima; Joseph A Delaney; Matthew J Feinstein; Sanjiv J Shah; Russel P Tracy; Bruce M Psaty Journal: JCI Insight Date: 2021-07-08